- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| AAC HOLDINGS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 35,700 | -1,71 % | ANALYSE-FLASH: Jefferies belässt Siemens Healthineers auf 'Buy' - Ziel 60 Euro | NEW YORK (dpa-AFX) - Das Analysehaus Jefferies hat Siemens Healthineers vor den am 7. Mai erwarteten Zahlen zum zweiten Geschäftsquartal mit einem Kursziel von 60 Euro auf "Buy" belassen. Das Update... ► Artikel lesen | |
| TELADOC HEALTH | 4,743 | -0,92 % | Teladoc Health Q4 Loss Narrows | WASHINGTON (dpa-AFX) - Teladoc Health, Inc. (TDOC) on Wednesday reported a fourth-quarter net loss of $25.1 million, or $0.14 per share, compared to $48.4 million or $0.28 per share last year.Fourth-quarter... ► Artikel lesen | |
| ROKU | 74,33 | -4,15 % | Aurzen Official: Aurzen Announces Big Spring Sale for Aurzen Roku TV Smart Projectors | Designed to simplify both performance and usability, with a built-in Roku TV OS, Aurzen Roku TV Smart Projectors allow users to access thousands of streaming channels and apps instantly-without external... ► Artikel lesen | |
| BECTON DICKINSON | 135,50 | -0,70 % | Argus cuts Becton Dickinson stock price target on market turbulence | ||
| FAMICORD | 4,800 | +1,27 % | FAMICORD AG im Fokus - klare Schwäche, klare Linie | ||
| BOSTON SCIENTIFIC | 60,40 | -1,63 % | Boston Scientific HI-PEITHO Trial Shows EKOS System Superior In Acute Pulmonary Embolism Treatment | WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) announced positive data from the HI-PEITHO global randomized clinical trial evaluating the use of the EKOS Endovascular System in patients... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 143,05 | -1,17 % | ALIGN TECHNOLOGY INC - Schwäche mit Signalcharakter | ||
| BAXTER | 14,350 | -0,91 % | Manufacturing Disruption Hits Baxter Cancer Drug Supply In Europe | ||
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update | SEATTLE, March 25, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing... ► Artikel lesen | |
| ELEVANCE HEALTH | 255,70 | +0,16 % | Cantor Fitzgerald reiterates Elevance stock rating with $400 target | ||
| AMN HEALTHCARE SERVICES | 16,700 | +4,38 % | AMN Healthcare Services Inc: AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results | Quarterly revenue of $748 million- GAAP loss of ($0.20)/share and adjusted EPS of $0.22DALLAS, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 2,300 | -4,96 % | SINTX Technologies, Inc.: SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution | Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026 SALT LAKE CITY, Utah, March 23, 2026 (GLOBE NEWSWIRE) -- SINTX... ► Artikel lesen | |
| AVANOS MEDICAL | 11,900 | +1,71 % | Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results | Exceeded full-year revenue and achieved the top end of full-year earnings-per-share guidance
Delivered full-year organic growth of 6% in strategic segments
Expanded... ► Artikel lesen | |
| AXOGEN | 27,200 | +0,74 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| ALPHATEC | 9,524 | +0,85 % | Alphatec Holdings, Inc. and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion | ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment
Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering... ► Artikel lesen |
AAC HOLDINGS INC gehört der Branche Gesundheitswesen an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AAC HOLDINGS INC finden Sie auf Wallstreet Online.